225 related articles for article (PubMed ID: 31811153)
21. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming.
Tanaka Y; Hysolli E; Su J; Xiang Y; Kim KY; Zhong M; Li Y; Heydari K; Euskirchen G; Snyder MP; Pan X; Weissman SM; Park IH
Stem Cell Reports; 2015 Jun; 4(6):1125-39. PubMed ID: 26004630
[TBL] [Abstract][Full Text] [Related]
22. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation.
Huynh LM; Shinagawa T; Ishii S
Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967
[TBL] [Abstract][Full Text] [Related]
23. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
Oh HR; Kim J; Kim J
FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
[TBL] [Abstract][Full Text] [Related]
24. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
25. Directing reprogramming to pluripotency by transcription factors.
Adachi K; Schöler HR
Curr Opin Genet Dev; 2012 Oct; 22(5):416-22. PubMed ID: 22868173
[TBL] [Abstract][Full Text] [Related]
26. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
[TBL] [Abstract][Full Text] [Related]
27. In vitro effects of reprogramming factors on the expressions of pluripotent genes and CD
Zhu LF; Xiao M; Chen YQ; Wang LY; Luo XF; Yuan XH; Ren JH; Chen ZZ; Hu JD; Yang T
Genomics; 2017 Oct; 109(5-6):331-335. PubMed ID: 28533192
[TBL] [Abstract][Full Text] [Related]
28. Roadmap of the Early Events of
Guallar D
Cell Reprogram; 2023 Feb; 25(1):7-8. PubMed ID: 36695734
[TBL] [Abstract][Full Text] [Related]
29. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.
Samavarchi-Tehrani P; Golipour A; David L; Sung HK; Beyer TA; Datti A; Woltjen K; Nagy A; Wrana JL
Cell Stem Cell; 2010 Jul; 7(1):64-77. PubMed ID: 20621051
[TBL] [Abstract][Full Text] [Related]
30. Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer.
Hong L; Hong S; Zhang X
Medicine (Baltimore); 2023 Dec; 102(48):e36433. PubMed ID: 38050242
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
32. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
33. Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs.
Cevallos RR; Edwards YJK; Parant JM; Yoder BK; Hu K
Sci Rep; 2020 Nov; 10(1):19710. PubMed ID: 33184372
[TBL] [Abstract][Full Text] [Related]
34. Cooperative Binding of Transcription Factors Orchestrates Reprogramming.
Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K
Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071
[TBL] [Abstract][Full Text] [Related]
35. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
36. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.
Chen Y; Lüttmann FF; Schoger E; Schöler HR; Zelarayán LC; Kim KP; Haigh JJ; Kim J; Braun T
Science; 2021 Sep; 373(6562):1537-1540. PubMed ID: 34554778
[TBL] [Abstract][Full Text] [Related]
37. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
38. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
39. SCNT versus iPSCs: proteins and small molecules in reprogramming.
Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
[TBL] [Abstract][Full Text] [Related]
40. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
